2m 2m 2m 2m 2m 2m 2m
ANI Pharmaceutic (ANIP)
NASDAQ
$72.24-$0.72 (-0.99%)
Price as of Oct 02, 2026 6:07 PM EDT- $1.7BMarket Cap
- -18.14%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ANI Pharmaceutic (ANIP)
$72.24-$0.72 (-0.99%)
Top Holders
Institutional
Mutual Funds
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
BLACKROCK, INC. | 13.01% | 3.0M | +211,154 (+7.14%) | Jun 30, 2026 |
BLACKROCK FUNDING, INC. /DE | 12.05% | 2.7M | +48,860 (+1.78%) | Dec 31, 2024 |
BLACKROCK INC. | 11.68% | 2.7M | +125,172 (+4.71%) | Jun 30, 2024 |
VANGUARD GROUP INC | 5.74% | 1.3M | +27,598 (+2.11%) | Dec 31, 2025 |
SOLEUS CAPITAL MANAGEMENT, L.P. | 3.82% | 867,760 | +47,517 (+5.48%) | Jun 30, 2026 |
VANGUARD CAPITAL MANAGEMENT LLC | 3.69% | 838,224 | +15,160 (+1.81%) | Jun 30, 2026 |
STATE STREET CORP | 3.66% | 831,647 | +60,060 (+7.22%) | Jun 30, 2026 |
Holder | Ownership %
| Shares Held | Change (Shares, %) | Report Date |
|---|---|---|---|---|
VANGUARD INDEX FUNDS | 3.60% | 818,536 | +15,963 (+1.95%) | Jun 30, 2026 |
AMERICAN CENTURY ETF TRUST | 1.81% | 412,268 | +316,832 (+76.85%) | May 31, 2026 |
SPDR SERIES TRUST | 1.57% | 356,973 | 0 (0.00%) | Jul 31, 2026 |
DFA INVESTMENT DIMENSIONS GROUP INC | 1.46% | 332,199 | +42,049 (+12.66%) | Jul 31, 2026 |
INVESCO EXCHANGE-TRADED FUND TRUST | 1.34% | 305,430 | +48,721 (+15.95%) | Jul 31, 2026 |
OBERWEIS FUNDS | 1.13% | 256,300 | +43,800 (+17.09%) | Jun 30, 2026 |
FIDELITY SALEM STREET TRUST | 1.00% | 227,165 | +207,910 (+91.52%) | Jul 31, 2026 |
Current Ownership Distribution
- Institutions295.6M (69.47%)
- Mutual Funds122.5M (28.78%)
- Insiders7.4M (1.75%)
- Other0 (0.00%)
Insider Transactions
- 1.75% (7.4M)Current InsiderOwnership (%, shares)
- 0Number of InsiderBuying (last 12 months)
- $0.00Amount of InsiderBuying (last 12 months)
- 10Number of InsiderSelling (last 12 months)
- $240.9MAmount of InsiderSelling (last 12 months)
Insider Name & Title | Type | Date
| Transaction Value | Shares | Share Price | Shares After Transactions |
|---|---|---|---|---|---|---|
CAREY STEPHEN P. SVP & CFO | Sell | Sep 29, 2026 | $208,050.00 | 2,850 | $73.00 | 168,993 |
Lalwani Nikhil PRESIDENT & CEO | Sell | Sep 15, 2026 | $383,400.00 | 5,400 | $71.00 | 339,089 |
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sell | Sep 14, 2026 | $35,395.00 | 500 | $70.79 | 73,924 |
Thoma Jeanne | Sell | Sep 11, 2026 | $71,530.00 | 1,000 | $71.53 | 26,762 |
CAREY STEPHEN P. SVP & CFO | Sell | Aug 31, 2026 | $207,480.00 | 2,850 | $72.80 | 171,843 |
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sell | Aug 13, 2026 | $37,740.00 | 500 | $75.48 | 74,424 |
CAREY STEPHEN P. SVP & CFO | Sell | Jul 29, 2026 | $231,876.00 | 2,850 | $81.36 | 174,693 |
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sell | Jul 13, 2026 | $40,920.00 | 500 | $81.84 | 77,390 |
CAREY STEPHEN P. SVP & CFO | Sell | Jun 29, 2026 | $239,742.00 | 2,850 | $84.12 | 177,543 |
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sell | Jun 12, 2026 | $41,015.00 | 500 | $82.03 | 77,890 |
HAUGHEY THOMAS | Sell | Jun 08, 2026 | $161,760.00 | 2,000 | $80.88 | 38,878 |
Thoma Jeanne | Award | May 21, 2026 | $0.00 | 4,357 | $0.00 | 27,762 |
HAUGHEY THOMAS | Award | May 21, 2026 | $0.00 | 4,357 | $0.00 | 40,878 |
TANNENBAUM RENEE P | Award | May 21, 2026 | $0.00 | 4,357 | $0.00 | 29,514 |
Mutz Christopher HEAD OF RARE DISEASE | Sell | Mar 13, 2026 | $226,525.68 | 3,162 | $71.64 | 91,309 |
Cook Meredith SR. VP, GENERAL COUNSEL & SEC. | Sell | Mar 13, 2026 | $36,310.00 | 500 | $72.62 | 79,390 |
Rowland Thomas Andrew SVP, HEAD - ESTABLISHED BRANDS | Sell | Mar 11, 2026 | $357,470.52 | 4,772 | $74.91 | 38,730 |
Davis Krista SVP, CHIEF HR OFFICER | Sell | Mar 09, 2026 | $377,099.31 | 5,087 | $74.13 | 51,946 |
Mutz Christopher HEAD OF RARE DISEASE | Sell | Mar 09, 2026 | $267,196.36 | 3,602 | $74.18 | 94,471 |
CAREY STEPHEN P. SVP & CFO | In Kind | Mar 07, 2026 | $381,306.00 | 5,150 | $74.04 | 180,393 |
Lalwani Nikhil PRESIDENT & CEO | In Kind | Mar 07, 2026 | $1.3M | 17,060 | $74.04 | 404,889 |
Mutz Christopher HEAD OF RARE DISEASE | In Kind | Mar 07, 2026 | $245,368.56 | 3,314 | $74.04 | 98,073 |
Davis Krista SVP, CHIEF HR OFFICER | Sell | Mar 06, 2026 | $111,375.00 | 1,485 | $75.00 | 57,033 |
Mutz Christopher HEAD OF RARE DISEASE | Sell | Mar 06, 2026 | $157,420.62 | 2,121 | $74.22 | 101,387 |
CAREY STEPHEN P. SVP & CFO | Exempt | Mar 05, 2026 | $163,977.12 | 3,312 | $49.51 | 9,938 |
CAREY STEPHEN P. SVP & CFO | Exempt | Mar 05, 2026 | $163,977.12 | 3,312 | $49.51 | 192,855 |
CAREY STEPHEN P. SVP & CFO | Sell | Mar 05, 2026 | $249,791.04 | 3,312 | $75.42 | 189,543 |
CAREY STEPHEN P. SVP & CFO | Sell | Mar 05, 2026 | $302,240.00 | 4,000 | $75.56 | 185,543 |
Walsh Patrick D | Sell | Mar 03, 2026 | $445,380.00 | 6,000 | $74.23 | 52,405 |
Gutwerg Ori SVP, GENERICS | Sell | Mar 03, 2026 | $157,590.00 | 2,060 | $76.50 | 84,782 |